STAAR Surgical | STAA - Equity Capital And Reserves


STAAR Surgical reported $352.37M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Bausch Health Companies USD -802M 1.26B Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Cerus USD 64.22M 2.76M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
J&J USD 84.97B 3.78B Jun/2026
Merit Medical Systems USD 1.68B 53.08M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Orthofix International USD 429.18M 6.01M Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Utah Medical Products USD 120.37M 1.1M Mar/2026